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Abstract 
The goals of the present work are to evaluate the sensitizing/protective effect of 
melanin in the cytotoxicity and genotoxicity of ionizing radiation, including induced oxidative 
stress modulation in malignant melanoma cells in presence and absence of melanin, and to 
interpret obtained results in the perspective of melanoma or other malignancies radiotherapy. 
An overview about the generality of skin cancers with special attention to malignant 
melanoma is presented. Skin cancer incidence has been steadily increasing over the last 40 
years; however the mortality has been decreasing, mainly due to early diagnosis and 
prevention campaigns. Although malignant melanoma (MM) represents only 7% of total 
number of skin cancers, it is responsible for more than 80% of deaths attributable to skin 
cancers. MM presents higher incidence rates in light skinned populations, and in individuals 
chronically exposed to the sun, but a relatively high MM incidence has been reported in 
subjects exposed to ionizing radiation (IR), indicating that may there to be a causal relationship 
between MM and IR. 
The biological effects of ionizing radiation interaction are explored with special focus 
on the biologic effects of radiation in normal and melanoma cells and the interaction of 
melanin with the damage caused by IR. Melanin is a class of pigments present in almost all 
living beings. Melanin protection against UV radiation is widely acknowledged, but not 
completely understood; some recent studies claim that melanin can also play an in important 
role in protection against ionizing radiation. However, other studies evidenced that 
melanogenesis, the process by which melanocytes produce melanin, may be a source of 
reactive substances, some of them carcinogenic. This study is an attempt to clarify which 
behavior prevails in IR-exposed cells. 
In this work B16-F1 cells (mouse melanoma line) were irradiated at 1.5 Gy in the 
presence and absence of several concentrations of melanin, either added to the medium or 
obtained by melanogenesis induction using different concentrations of L-tyrosine as a 
precursor during cell growth. To assess genotoxic effects, cytocinesis-block micronucleus assay 
was performed. MTT assay reveals the level of cytotoxicity and cell death by comparing control 
and irradiated cell ability to reduce MTT salt to formazan (only metabolically active cells are 
able to complete this process). Lipid peroxidation may result from the indirect action of IR, by 
the intermediate reactive oxygen species generated in the intracellular and extracellular 
medium. Lipid peroxidation products were quantified in the supernatant of cell cultures by the 
thiobarbituric acid reaction, expressed as malondialdehyde, as a measure of oxidative stress 
MDA-TBA reaction assay giving an idea of oxidative stress products production. 
The obtained results strongly suggest that melanin may play an important role in 
protection against ionizing radiation. This conclusion provides a partial explanation as to why 
MM has a strong radiotherapy resistance; however melanin could be applied in melanin-based 
radioprotective materials, suitable for internal administration to prevent side effects in normal 
tissues during radiotherapy. 
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Future prospects include an investigation on melanin behaviour when irradiated with 
particulate ionizing radiation. It would also be interesting to attempt to develop biomaterials 
similar to melanosomes, in the form of nanospheres, enabling the internal administration of 
melanin, via intravenous injection, for instance, to test melanin protection in vivo. 
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Resumo 
Os objectivos do presente trabalho são: avaliar o efeito sensibilizante ou protector da 
molécula de melanina na citotoxicidade e genotoxicidade da radiação ionizante, investigar a 
modulação do stress oxidativo radioinduzido em células de melanoma maligno na presença e 
ausência de melanina e interpretar os resultados na perspectiva da radioterapia do melanoma 
ou outras neoplasias malignas. 
É ainda apresentada uma revisão bibliográfica acerca dos cancros cutâneos com 
especial atenção para o melanoma maligno (MM). A incidência do cancro da pele tem vindo a 
aumentar nos últimos 40 anos, porém a mortalidade tem diminuído, principalmente graças às 
campanhas de sensibilização para os sinais de alerta, que conduzem a um diagnóstico mais 
precoce e com melhor prognóstico. No conjunto dos cancros da pele, embora o MM 
represente apenas 7% da totalidade de casos, é responsável por mais de 80% das mortes 
atribuíveis a esta neoplasia: para tal contribui o seu carácter invasivo e a sua resistência aos 
tratamentos por radio e quimioterapia. O MM apresenta maior incidência em populações 
onde predominam fotótipos de pele clara, entre outros factores de risco incluindo exposição 
crónica a radiação UV, no entanto foi também notada uma taxa de incidência aparentemente 
aumentada em indivíduos expostos a radiação ionizante, indicando uma possível relação 
causal entre a radiação ionizante e o MM. 
Neste trabalho explora-se a interacção da radiação ionizante com células eucariotas, 
com principal incidência nos efeitos radiobiológicos e na interacção com a molécula de 
melanina. A melanina é uma classe de pigmentos presente na maior parte dos seres vivos. São 
largamente conhecidas as propriedades protectoras da melanina contra a radiação UV, apesar 
de não estarem completamente explicadas; paralelamente, alguns estudos recentes sugerem 
que a melanina pode apresentar também propriedades radioprotectoras. Contudo, outros 
autores apontam a melanogénese (processo pelo qual os melanócitos produzem melanina) 
como potencial fonte de substâncias citotoxicas, algumas delas carcinogénicas. O presente 
trabalho tenta contribuir para clarificar qual a acção da melanina que prevalece em células de 
MM expostas a radiação ionizante. 
Para este trabalho foram irradiadas células B16-F1 de melanoma de ratinho com uma 
dose aguda de radiação gama de 1,5 Gy com diferentes concentrações de melanina no meio 
de cultura, obtidas quer por adição de melanina ao meio, quer por indução/inibição da 
produção de melanina na presença e ausência de L-tirosina durante o crescimento celular. 
Para avaliar os efeitos genotóxicos procedeu-se ao ensaio do micronúcleo com citocinese 
bloqueada. A toxicidade aguda foi avaliada pelo ensaio do MTT que quantifica a viabilidade 
celular, comparando a capacidade das células de controlo e irradiadas de reduzir o sal MTT 
para formazan (composto corado). Avaliou-se ainda a peroxidação lipídica resultante da acção 
das espécies reactivas geradas no meio intra e extracelular devido à exposição a radiação 
ionizante. Quantificaram-se os produtos de peroxidação lipídica, que reflectem o stress 
oxidativo da amostra, através da reacção com o ácido tiobarbiturico (TBA), sendo expressos 
em equivalentes de malondialdeído (MDA). 
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Os resultados obtidos sugerem fortemente que a melanina exerce um papel 
importante na protecção contra a radiação ionizante. Este facto contribui para explicar a 
grande radiorresistência do MM perante a radioterapia; porém a melanina poderia ser usada 
na produção de materiais radioprotectores passíveis de administração intracorporal de modo a 
proteger os tecidos saudáveis dos efeitos colaterais da radioterapia. 
De futuro aconselha-se investigar o comportamento da melanina quando irradiada 
com radiação particulada. Seria também interessante o desenvolvimento de biomateriais 
semelhantes a melanossomas, tais como nanoesferas, permitindo administrar melanina 
internamente, por exemplo por via intravenosa, permitindo experiências in vivo.  
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Objectives 
The objectives of this work are: 
- To study melanin sensitizing/protective effects in cytotoxicity and genotoxicity 
induced by ionizing radiation 
- To evaluate oxidative stress modulation in malignant melanoma cells in the presence 
and absence of melanin 
- To interpret the results in the perspective of radiotherapy success in malignant 
melanoma or other neoplasic malignancies. 
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Skin Cancer and Melanoma 
Skin cancer is the more frequent malignancy among Caucasian individuals. Its 
incidence has been steadily increasing over the last 40 years (J. A. Amaro 2009). Early 
treatment is usually simple with high rates of cure (> 90%). However, advanced stages of the 
disease require complex and expensive treatment with relatively reduced cure probability, 
possibly ending with death of the patient. Prevention is, therefore, the best practice: 
 Primary prevention – the main causal factors are well known and potentially 
avoidable; 
 Secondary prevention or early diagnostic - skin is an easily accessible organ for 
direct observation so detection of skin cancer at early stages is possible and enables 
a good prognosis. 
Skin cancer has low global mortality rate due to a highly efficient early diagnostic and 
treatment. However, its importance should not be underestimated: this disease has a high 
aggressiveness and morbidity, with a deep negative impact in patients’ and their families’ 
quality of life. 
Skin Cancer Types 
Skin cancers are divided essentially in three groups: 
1. Keratinocytic or epidermal carcinomas, derived from epidermal keratin-producer 
cells including: 
a. Basal cell carcinoma or basilioma (BCC); 
b. Squamous cell or spino-cellular carcinoma (SCC); 
2. Malignant Melanoma (MM), derived from melanin-producer cells, the melanocytes; 
3. Other skin malignancies, including skin lymphomas and Kaposi sarcoma. 
Incidence has been increasing in all kinds of skin cancer; especially in MM. Epidermal 
carcinomas are, by far, the most frequent skin tumors, representing about 90% of all kinds of 
skin cancers, 65% corresponds to BCC and 25% to SCC. MM represents about 7% and 3% to 
other tumors heterogenic group (Table 1 and Fig. 1) (J. A. Amaro 2009). 
Table 1 - Relative incidence of skin cancer types (J. A. Amaro 2009) 
Skin cancer types Incidence 
(%) 
BCC 65 
SCC 25 
MM 7 
Other Tumors 3 
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Fig. 1 - Relative frequency of skin cancer types (J. A. Amaro 2009). BCC Basal Cell Carcinoma; SCC – Squamous Cell 
Carcinoma; MM – Malignant Melanoma. 
Despite MM represent only 7% of the total number of skin cancers; it is responsible for 
more than 80% of deaths attributable to this malignancy. It is ten times more frequent today 
than in the 60’s and its incidence has more than duplicated in the last 15 years and its trend is 
for a continuous increase (J. A. Amaro 2009). 
Occupational chronic sun exposure is the main etiology for BCC and SCC; however 
people with acute sun exposure are at higher risk of MM, usually caused by coastal sun 
exposure (Ribas dos Santos 2009). 
Non Melanoma Skin Cancers 
As previously stated, epidermal carcinomas are, by far, the most frequent skin cancers, 
representing about 90% of all malignant skin tumors. This type of skin cancer mainly affects 
light-skinned populations, with low incidence in Asians and Latin-Americans, and a very low 
frequency in Negroid population (World Health Organization 2008). Basal cell carcinoma and 
squamous cell carcinoma are the two main forms of epidermal, non-melanoma skin cancer. 
SCC occurs almost always in chronically sun-exposed skin areas, whereas BCC may also 
occur in areas exposed to the sun only intermittently. Non-melanoma skin cancers have higher 
incidence in Caucasian populations residing in areas close to Equator (Australia), showing an 
important variability between Europe, the USA and Australia: incidence rates are about 5 times 
higher in the USA and 20-40 times higher in Australia than in Europe (World Health 
Organization 2008). 
BCC and SCC are slow-growing tumors that are locally invasive, rarely resulting in 
distant metastasis.  
Basal Cell Carcinoma or Basilioma (BCC) 
BCC is the most frequent skin cancer; its incidence is listed in Table 2. Its origin is in the 
basal layer of the epidermis and it mostly affects Caucasian individuals chronically exposed to 
the sun: agricultural workers, fishermen, construction workers, etc. More often, this kind of 
cancer manifests itself after the 4th decade of life, and preferentially in most exposed body 
BCC
65%
SCC
25%
MM
7%
Other Tumors
3%
Most Frequent Skin Cancer Types
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areas such as face, neck and torso. It may present itself as a slow-growing, shinning and pink 
node or superficial wound, with no apparent cause and no spontaneous healing tendency (J. 
Amaro 2009). 
BCC is a localized only invasive tumor, not metastatic. Treatment in early stages is very 
simple (surgery, cryosurgery and laser) with good prognosis (healing rates higher than 95%). It 
may become more aggressive in later stages, invading surrounding tissues and causing 
permanent damages and mutilations in certain anatomical areas (nose, ear, eyelid, etc.). Even 
in these advanced stages cure is often possible with surgery and radiotherapy (J. Amaro 2009). 
Squamous cell carcinoma (SCC) 
SCC is the second most frequent skin cancer; its incidence is listed in Table 2. Its origin 
is in the stratified spinosum squamous epithelium cells and it is most frequent among the same 
population as BCC, but at elder ages: its incidence increases with age (exponential increase, 
doubling in last 25 years of the individual’s life span) and in patients with more sun-aged skin, 
preferentially in the most exposed body areas such as face, neck, back of the hands and legs. It 
appears almost always over pre-existing lesions or in patients chronically exposed to 
carcinogenic agents (tobacco, X-rays, arsenic, tar and derivatives) (J. Amaro 2009). It’s 
estimated that SCC’s incidence will continue to increase due to population aging and 
environmental factors like ozone layer deterioration (J. A. Amaro 2009). 
SCC is more aggressive and faster growing than BCC, being responsible for the majority 
of non melanoma skin cancer mortality, accounting for around 75% of all non-melanoma skin 
cancer deaths (World Health Organization 2008). In most cases it’s manifested as a fast 
growing node, with ulcer and bleeding tendency. In addition to being locally invasive it may 
metastise, however, with early diagnostic, has high chances of cure (J. A. Amaro 2009). Despite 
the increasing incidence, SCC mortality (Fig. 2) has decreased 20% in last 20 years in Portugal 
mainly due to early diagnosis and treatment, consequences of the better national medical 
coverage and information campaigns after 1988 (J. A. Amaro 2009). 
Table 2 - Incidence rates in several countries, per year and per 100.000 inhabitants (J. A. Amaro 2009) 
Country Basal Cell Carcinoma (BCC) Squamous Cell Carcinoma (SCC) 
Men Women Men Women 
Australia 2024 1579 1035 472 
U.S.A. 247 150 65 24 
United Kingdom 112 54 32 6 
Portugal 85 65 19 11 
Switzerland 52 38 16 8 
Finland 49 45 9 5 
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Fig. 2 - Mortality rates from non-melanoma skin cancer for men (left) and women (right) in Europe between 1993-
1997
1
 (World Health Organization 2008).  
BCC and SCC risk factors 
Adapted from: (J. A. Amaro 2009) 
Environmental factors 
 Sun exposure (UVA and UVB) 
 Artificial UV tanning 
 Ionizing radiation (occupational, medical, accidental) 
Chemical agents 
 Arsenic (industrial, environmental, drugs) 
 Polycyclic aromatic hydrocarbons (oil and tar derivatives) 
 Tobacco 
Biological agents 
 Human papillomavirus (HPV) 
Genetic factors 
 Bright skin (Phototypes I and II) 
 Genodermatosis 
o Albinism 
o Xeroderma pigmentosa ( autosomal recessive genetic disorder of DNA 
repair in which the ability to repair damage caused by UV light is deficient) 
o Nevoid Basal Cell Carcinoma Syndrome (autosomal dominant condition that 
can cause unusual facial appearances and a predisposition for basal cell 
carcinoma) 
Immunosuppression 
 Organ transplant 
 Cancer treatments 
 AIDS 
                                                          
1 European Community including countries of the EFTA (Switzerland, Iceland and Norway). The main map 
represents the relative distribution of rates using a scale from lower rates in green to highest rates in red using 
percentiles of the distribution of rates. The second map represents the distribution of rates using an absolute scale 
and the upper right sub-Figure contains the distribution of rates and boxplots of rates by country. 
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Other skin tumors 
Besides epidermal carcinomas and melanoma, there are an enormous variety of other 
skin cancers (Table 3), much less frequent, and whose origin does not seem to be related to 
sun exposure. 
Table 3 - Other non-melanoma cutaneous malignancies (Harrison's 2005) 
Tumor Type Most common 
location 
Recurrence rate, % Metastatic rate, % 
Atypical fibroxanthoma Head and neck 21 4 
Merker cell carcinoma Head and neck 40 75 
Dermatofibrosarcoma 
protuberans 
Trunk 50 1 
Sebaceous carcinoma Eyelid 12 30 
Microcystic adnexal 
carcinoma 
Face 50 1 case 
Porocarcinoma Extremity 20 10 
Eccrine carcinoma Head and neck 36 11 
Angiosarcoma Head and neck 75 75 
 
In this heterogeneous group it is worth to refer skin lymphomas and Kaposi sarcoma. 
Skin lymphomas 
Lymphatic system cancers that primary appear at skin level with still unknown etiology. 
There are two major types: 
1. T-lymphocytes skin lymphomas: some tumors look like mushrooms, so its 
classic clinic form is called “fungous mycosis”. 
2. B-lymphocytes skin lymphomas: low malignancy lymphomas, however 
generally higher malignancy than T-lymphomas. 
Treatment varies with disease’s stage; includes often photo-chemotherapy (UV 
exposure after photosensitizing drug ingestion), interferon immunotherapy, 
radiotherapy and chemotherapy (J. Amaro 2009). 
Kaposi sarcoma 
This kind of cancer targets primarily skin and mucosae, and shows an appearance of 
multiple spots and red-violet nodes. It was, until recently, a relatively rare disease, affecting 
mainly the inferior limbs of males over 50 years of age, in Mediterranean and African 
countries, where it is an endemic disease. However, with the growing number of cases of 
acquired immunodeficiency syndrome (AIDS), the incidence of Kaposi sarcoma exponentially 
increased, frequently affecting patients with AIDS. Although in the classic variant the disease 
evolution is relatively slow and with good prognosis, when associated with AIDS it has a fast 
evolution and is more aggressive. In early stages, radiotherapy is an efficient treatment in 
localized lesions; in later stages chemotherapy is needed. Recent studies seem to point to 
Herpes virus type 8 (HSV-8) as probable etiology (J. Amaro 2009).  
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Malignant Melanoma 
History 
The first report of a melanoma was by Hippocrates in the 5th century B.C. The next 
reference we can find is by Rufus of Ephesus (60? - 120?), a Greek physician widely known 
among the ancients for his descriptions of the meninges, the crystalline lens, the optic chiasm, 
the synchronism of the heart beat and the pulse, filariasis, gout and certain cancers of the skin, 
notably melanoma (Urteaga and Pack 1966). 
Although melanoma is not a new disease, evidence for its occurrence in antiquity is 
rather scarce. However, one example lies in a 1960s examination of nine Peruvian Inca 
mummies, radiocarbon-dated to be approximately 2400 years old, which showed apparent 
signs of melanoma: melanotic masses in the skin and diffuse metastases to the bones (Fig. 3). 
(Urteaga and Pack 1966) 
 
Fig. 3 - A and B. Pre-Colombian Inca skulls containing metastatic melanoma in bone (Urteaga and Pack 1966). 
John Hunter (a Scottish surgeon regarded as one of the most distinguished scientists 
and surgeons of his day, the Hunterian Society of London was named in his honor) is reported 
to be the first to operate on metastatic melanoma in 1787. Although not knowing precisely 
what it was, he described it as a "cancerous fungous excrescence". The excised tumor was 
preserved in the Hunterian Museum of the Royal College of Surgeons of England. It was not 
until 1968 that microscopic examination of the specimen revealed it to be an example of 
metastatic melanoma (Bodenham 1968). 
Eiselt, in 1861-1862, discussing pigmented tumors, stated that the description of “fatal 
black tumors with metastases and black fluid in the body” can be found in Highmore (1651), 
Bartholin (1677), Bonet (1679), and Henrici and Nothnagel (1757).The French physician René 
Laennec was the first to describe melanoma as a disease entity. His report was initially 
presented during a lecture for the Faculté de Médecine de Paris in 1804 and then published as 
a bulletin in 1806. Robert Carswell, in 1838, first employed the term melanoma to designate 
these pigmented malignant tumors (Urteaga and Pack 1966).  
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The first formal acknowledgment that advanced stages of melanoma are untreatable 
came from Samuel Cooper in 1840. He stated that 'the only chance for benefit depends upon 
the early removal of the disease ...' (Cooper 1840) More than one and a half centuries later this 
situation remains largely unchanged. 
Epidemiology 
MM has an incidence of about 160 000 new cases worldwide each year (approximately 
79 000 males and 81 000 women), of which almost 80% are in Oceania, Europe and North 
America (Fig. 4) (World Health Organization 2008). On a global scale, MM is the 16th and 15th 
most commonly diagnosed cancer in males and females (respectively), but has significant 
regional variation, with higher incidence in Australia and New Zealand (4th most common 
males, 3rd in females), North America (6th in males, 5th in females) and Europe (16th in males, 8th 
in females) (World Heath Organization 2006). 
 
Fig. 4 - Incidence of melanoma worldwide in men (left) and women (right) at all ages (World Health Organization 
2008) 
The highest incidence of melanoma occurs in Australia where the population is 
predominantly Caucasian, mostly Northern European descendents. In Western Europe 
incidence rates are higher in the North than in the South (Fig. 5) (World Heath Organization 
2006) reflecting the protective effect of melanin presence in the southern populations. U.S. 
caucasoids have rates 15 times higher than U.S. negroids, and a similar contrast is observed in 
South Africa and Zimbabwe. Melanoma is also relatively uncommon among Asians and 
Central/South American populations (Table 4 and Figure 6). 
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Table 4 - Melanoma incidence in several world countries (J. A. Amaro 2009) 
Country Incidence rate per 100.000 inhabitants 
Men Women 
Australia, Queensland 51.1 38.1 
Australia, South New Wales 36.9 25.9 
New Zealand 32.8 30.6 
U.S.A 15.4 11.6 
Sweden 11.8 11.9 
Israel 11.7 11.3 
Denmark 10.5 13.4 
Netherlands 8.0 10.9 
Czech Republic 8.1 7.9 
Scotland 7.1 9.9 
England 5.8 7.4 
Germany 6.3 6.1 
Spain 4.1 5.4 
Portugal 3.8 5.0 
Japan 0.4 0.5 
China 0.3 0.2 
India 0.3 0.2 
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Fig. 5 The prominent features of the geographical distribution of melanoma in men (top) and women (bottom) 
are the high levels across (southern) Finland, Norway, Sweden and Denmark and into northern Germany and The 
Netherlands, in Austria, Switzerland, the Czech Republic, Slovakia, Hungary and Slovenia, and in southern 
England. Rates were low in most of Spain, Portugal, southern Italy and Greece (World Health Organization 2008) 
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Fig. 6 Age-standardized incidence rates for MM, per 100 000 inhabitants and year, adjusted to the world standard 
population (World Heath Organization 2006) 
Increasing incidence rates do not correspond to equivalent increasing mortality rates. 
This difference may be due to an earliest MM diagnostic and treatment, with good prognosis, 
or it may also be consequence of the worldwide prevention campaigns in the last 20 years 
Clinical Characteristics  
With rare exceptions, MM arises from atypical melanocytes situated along the dermal 
– epidermal junction (stratum basale of epidermis). MM in situ is confined to the epidermis, 
where there are neither blood vessels nor lymphatic vessels to enable metastases transport. 
When MM invades the dermis it gains access to vasculature (Cohen, et al. 2008). 
There are four main types of MM (Table 5). Three of these – superficial spreading 
melanoma (SSM), lentigo maligna melanoma (LMM) and acral lentiginous melanoma (ALM) – 
are characterized by a biphasic growth pattern: the lesion has a period of slower superficial 
(so-called “radial”) growth phase, succeeded by a more rapid, invasive “vertical” growth phase. 
During radial growth phase, lesion increases in size but does not penetrate deeply, undergoing 
centrifugal enlargement, and tending to be relatively flat. This period may persist for years, 
during which MM develops little, if any, tendency to metastise. It is during this period that MM 
has more chances of cure by surgical excision (Cohen, et al. 2008 and Harrison's 2005).The 
vertical growth phase appears to represent a new and distinct clone of tumor cells: the dome-
shaped nodule grows rapidly. During this invasive growth phase, the neoplasm penetrates the 
connective tissue, accessing blood and lymphatic vessels and resulting in metastasis. Nodular 
Melanoma (NM) exhibits a monophasic growth pattern, not having a recognizable radial 
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growth phase and usually presenting a vertical growth as a deeply invasive lesion from the 
outset, capable of early metastasis (Cohen, et al. 2008 and Harrison's 2005). The two growth 
phases are schematically represented in Fig. 7. 
Table 5 - Clinical features of the most common types of MM (Cohen, et al. 2008 and Harrison's 2005). 
Clinical 
feature 
Lentigo maligna 
melanoma (LMM) 
Superficial spreading 
melanoma (SSM) 
Nodular 
melanoma (NM) 
Acral lentiginous 
melanoma (ALM) 
Frequency 
in 
caucasoids 
≈ 10% ≈ 70% ≈ 10% ≈ 5% 
Site Sun-exposed 
surfaces, particularly 
malar region of 
cheek and temple 
Any site (more 
common on upper 
back and, in women, 
on lower legs) 
Any site  Palm sole, nail bed, 
mucous membrane 
Average 
age at 
diagnosis, 
years 
70 40-50 40-50 60 
Margin Flat Distinctly palpable Palpable: 
spheroid 
Flat 
Color In flat portions, 
shades of brown and 
tan predominant, 
but whitish gray 
occasionally present; 
in nodules, shades of 
reddish-brown, 
bluish black 
Shades of brown 
mixed with bluish red 
(violaceous), bluish 
black, reddish brown, 
and often whitish 
pink, and the border 
of lesions is at least 
part visibly and/or 
palpably elevated 
Reddish blue 
(purple) or bluish 
black; either 
uniform in color 
or mixed with 
brown or black 
In flat portions, dark 
brown 
predominantly; in 
raised lesions 
(plaques) brown-
black 
predominantly 
Growth 
pattern 
Biphasic – radial 
phase: lentiginous 
spread 5-20 years; 
vertical phase: rapid 
invasion of dermis 
over weeks to 
months 
Biphasic – radial 
phase: pagetoid 
spread 1-12 years; 
rapid invasion of 
dermis over weeks to 
months  
Monophasic – 
vertical phase 
from the outset; 
tumor present 
months to 2 
years at time of 
diagnosis 
Biphasic – radial 
phase: 1-10 years, 
of various histology; 
rapid invasion of 
dermis over weeks 
to months 
 
 
Fig. 7 – Left - Schematic representation of biphasic growth pattern. In radial growth phase, atypical melanocytes 
proliferate along the dermal–epidermal junction along a horizontal plane. In the vertical growth phase, atypical 
melanocytes penetrate toward deeper tissue levels. (Cohen, et al. 2008) Right - Imunoflourescent light 
micrography of melanoma cells (yellow) invading skin epithelial cells (green). (melanoma. [Photograph] n.d.) 
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Risk factors for Malignant Melanoma 
Adapted from (J. A. Amaro 2009) 
Constitutionals (Phenotypic) Factors 
1. Phototype (skin pigmentation capacity) 
 Bright skin (phototypes I and II) 
 Freckles formation tendency 
 Red or blond hair 
 Blue eyes 
2. Melanocytic nevi number, size and shape  
 More than 50 nevus 
 Diameter equal or bigger than 6mm 
 Congenital giant nevi 
 Atypical or dysplastic nevi 
Genetic (genotypic) factors 
Tumor activity suppressing genes mutations: 
 CDKV-2A and p53 genes mutations in sporadic melanoma 
 P16 and BRAF genes mutations in familiar melanoma 
 DNA repair defects (Xeroderma pigmentosa) 
Environmental factors 
 Intense and intermittent sun exposure (UVA and UVB) 
 Solar burns in childhood and adolescence 
 Artificial UV tanning 
 Ionizing radiation (occupational, medical, accidental) 
Immunosuppression 
 Organ transplant 
 Cancer treatments 
 AIDS 
Personal and familiar history 
Prognostic factors 
The most important prognostic factor is the stage at the time of presentation. 
Fortunately, most melanomas are diagnosed in clinical stages I and II. The revised staging 
system for melanoma is based on microscopic primary tumor depth (Breslow’s thickness), 
presence of ulceration, evidence of nodal involvement, presence of microscopic satellites and 
presence of metastatic disease (Fig. 8) (Harrison's 2005). 
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Fig. 8 - TMN classification of MM (World Heath Organization 2006) 
MM may recur after many years. About 10 to 15% of first-time recurrences develop >5 
years after treatment of the original lesion. The time to recurrence varies inversely with tumor 
thickness. An alternative prognostic scheme for clinical stages I and II melanoma, proposed by 
Clark, is based on the anatomical level of invasion of the skin: level I is intra-epidermal (in situ); 
level II penetrates the papillary dermis; level III spans the papillary dermis; level IV penetrates 
the papillary dermis and level V penetrates into the subcutaneous fat. The 5-year survival for 
these stages averages 100, 95, 82, 71 and 49%, respectively (Harrison's 2005). 
The aim of differential diagnosis is to distinguish benign pigmented lesions from 
melanoma and its precursors. If melanoma is a consideration, then biopsy is appropriate. 
Alarm signals that may indicate appearance of MM are: new dark brown mole or mole arising; 
alterations in a pre-existing mole (size, thickness, color, border, burning or itch sensation).  
Early detection of melanoma may be facilitated by applying the “ABCD rules”  (J. A. 
Amaro 2009) to distinguish benign acquired nevi forms from clinically atypical moles, potential 
melanoma precursors: 
A. asymmetry, benign lesions are usually symmetric; 
B. border irregularity, most nevi have clear-cut borders; 
C.  color variegation, benign lesions usually have uniform light and dark pigment; 
D. Diameter > 6 mm. 
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Melanoma and ionizing radiation 
Cancers types which have been strongly correlated with exposure to ionizing radiation 
include thyroid cancer (exposure to radioactive iodine), leukemia (especially acute myeloid 
leukemia, AML), female breast cancer, and lung cancer. However, the relationship between 
ionizing radiation exposure and skin cancers in general/MM in particular remains unclear. Fink 
and Bates 2005 authored a review in response to concerns that ionizing radiation could be a 
cause of MM. This review was prompted by debate surrounding an observed excess of MM 
amoung empoyees of the Lawrence Livermore National Laboratory, a nuclear energy and 
weapons laboratory located in California (Fink and Bates 2005). 
Studies presenting the relative risks for melanoma after ionizing radiation exposure fall 
in one of seven categories: 
1. The Canadian Radiation Dose Registry; 
2. Nuclear industy workers; 
3. Subjects near nuclear test blasts; 
4. Survivors of the atomic bombing in Japan; 
5. Airline pilots and cabine attendants; 
6. Recipiests of medical radiation; 
7. Radiological technicians. 
Gennerally, exposure categories with elevated relative risk of leukemia had 
proportionately elevated relative risks of MM (Fink and Bates 2005). 
Pilots and airline crew are occupationally exposed to elevated levels of cosmic 
radiation, primarily neutrons and γ rays. Recent studies have found elevated SIRs 
(standardized incidence ratios) for well known radio-induced cancers, such as breast cancer, 
leukemia (especially AML), tumors of central nervous system, and multiple myeloma (Fink and 
Bates 2005). Studies are shown in Table 6. 
Table 6 – Relative risk for MM and leukemia incidence in studies of aviation workers (Fink and Bates 2005) 
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The Canadian National Dose Registry and the Nuclear Industry workers group were the 
only two exposure categories where the risk of leukemia was generally not elevated, indicating 
that ionizing radiation exposure may have been lower than other categories. With the 
exception of these two categories the Fink and Bates review shows evidence for elevated 
relative risk for MM in every category of exposure to ionizing radiation examined, suggesting a 
relationship between ionizing radiation exposure and MM (Fink and Bates 2005). 
Some investigators atribute the MM SIRs in airline crews to leisure time spent in 
tropical locations, resulting in increased exposure to UV radiation, rather than a direct effect of 
exposure of cosmic rays (Fink and Bates 2005). In-flight UV radiation exposure of pilots is not 
thought to be relevant, because cockpit windows provide considerable UV radiation protection 
(Haldorsen, Reiten and Tveten 2001). One study by Gundestrup and Storm, 1999, found higher 
incidence in jet pilots that in non-jet pilots, being jet crews more exposed to cosmic radiation 
than commercial crews. According to Gundestrup and Storm, the rate of cosmic radiation 
exposure can doble with every 1500m increase in altitude. (Gundestrup and Storm 1999)  
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Radiobiology 
All living beings are constantly exposed to ionizing radiation. Environmental sources 
include cosmic radiation, earth radiation from inhaled and ingested materials. Air travels and 
mining activities increase background exposure. For instance, an air travel at 30 000 ft equals 
an equivalent dose of 0.5 mrem/h (5 µSv/h). Radiation originating from the body is mainly due 
to radioactive potassium, beta and gamma emitter. Lungs are exposed to radiation coming 
from inhaled air containing little amounts of radon. Cosmic radiation contributes with 280 µSv 
per year, while ground and internal sources with 260 and 270 µSv/year, respectively. Artificial 
sources mainly include medical related equipment, nuclear weapons and radioactive drugs. 
(Harrison's 2005) 
Radiobiologic Interaction 
Physical, chemical and biological phenomenon may occur when irradiating cells. Some 
tissues may be affected as consequence of cell damages, and then organs will be affected, 
spreading, finally, to whole body. This is a result of an interaction (energy transference) 
between radiation and the cells’ atoms. The absorption of energy from radiation often leads to 
excitation or ionization. Excitation involves elevation of electrons to a higher energy state 
without actual ejection of the electron. Ion pairs are formed when interaction is sufficient to 
remove electrons from atoms: in this case we have what is called ionizing radiation. Ionizing 
radiation is subclassified as particulate and electromagnetic radiation (Table 7). Each photon 
has a quantized amount of energy given by Plank equation: E=hν, where E is the amount of 
energy in joules (J, SI unit) or, commonly used, electron-volt (eV), h is the Plank’s constant 
(6,626 068 96×10−34 Js or 4,135 667 33×10−15 eV) and ν is radiation frequency in hertz (Hz = 1s-
1). 
Ionizing radiation may interact or not with irradiated tissues. Ionization occurs in three 
major ways:  
 The photoelectric effect; 
 The Compton effect; 
 Pair production.  
Photoelectric effect occurs at low energies (30 to 100 KeV). Here, the incident photon 
interacts with an electron from one of the outer shell of an atom (normally K, L or M) and 
ionization occurs if photon energy is greater than binding energy of the electron, in which case 
the electron is expelled from the orbit with a kinetic energy equal to the incident photon 
energy minus binding energy of the photon; upon returning to the initial shell, excited 
electrons emit non-ionizing electro-magnetic radiation, often UV radiation. 
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Table 7 - Common Types of Ionizing Radiation (modified from Harrison's 2005)  
Type Charge Comment 
Electromagnetic 
X-ray 0 X-rays and gamma rays 
only differ in the source. 
Gamma rays are produced 
by excited nucleus 
rearrangement, and x-rays 
are produced 
extranuclearly. 
Gamma raw 0 
Particulate 
Electron -1 
β
- 
particle. May be 
accelerated close to speed 
of light. Quick 
deceleration and low 
penetration in tissues. 
Positron +1 
β
+ 
particle. Similar to 
electron, when slowing 
interacts with electron 
producing 2 gamma 
photons with 511 KeV 
each. 
Proton +1 
Mass about 2000 times of 
electron. Exhibits Bragg 
peak, means that proton 
beams exert their effect in 
a relatively compact 
region. 
Neutron 0 
Uncharged particle, 
impossible to accelerate 
by an EM field. 
Alpha particle +2 
Helium nucleus: 2 protons 
+ 2 neutrons. Very low 
tissue penetration. 
 
Compton Effect occurs at higher energies, where incident photon interacts with an 
orbital electron not transferring all its energy. Part of the energy appears as kinetic energy of 
electrons and the residual energy continues as a less energetic deflected photon that may 
interact with another electron by Compton or photoelectric effect depending of its remaining 
energy.  
Pair production only occurs when incident photon energy is greater than 1,024 MeV. In 
this case, photons interact with the nucleus producing an electron and a positron with the 
same kinetic energy, equal to the incident photon energy minus 1,024 MeV. 
Physical phenomenons (atom ionization and the distribution of excitation energy 
throughout the cells) are the first to appear, followed by chemical phenomenons (free radical 
formation, due mainly to water radiolysis, and molecular bond breaking) and finally biological 
phenomenons that modify cell functions, morphology and normal activity, potentially leading 
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to cell death. These are the first reactions to ionizing radiation, generally occurring as a 
consequence of exposure to low doses. Main responsible for the cascade of events are the 
highly reactive free radicals, which lack a stable number of valence electrons. Cell damage is 
mainly due to hydroxyl radicals as follows:  
hν + H2O → H2O
+ + e- 
H2O
+ +H2O → H3O
+ + OH∙ 
OH∙ → Cell damage 
Reactive oxygen species (ROS) are generated inside the cell as byproducts of the redox 
reactions in which oxygen is involved. A well known source of ROS is the utilization of oxygen 
in mitochondria during oxidative process of energy (ATP) and water production  (Smit, et al. 
2008). 
According to modified Bergonie and Tribondeau law, cell susceptibility to ionizing 
radiation lesions is the same in different tissues, however, time of latency (period between 
irradiation and effect appearance) vary according to cell type and biological stress/effects will 
appear after cell division, making dividing cells (such as embryonary, epithelium, 
hematopoietic and tumor cells) more sensible to radiation-induced damage then mature slow 
or non-dividing cells (such as nervous cells). Consequently, different cells present different 
radio-sensitivity, so it is possible to classify living cells according to their division rate and 
radio-sensitivity: for instance, constant dividing hematopoietic cells are quite sensitive, in 
other hand, not so frequent dividing GI cells are less sensitive. Slow or non-dividing muscular 
and nervous cells are the least sensitive. 
Cell rescue is a set of biological pathways involved in cell damage repair. Four 
important processes that occur after radiation exposure can be summarized as the “four R’s” 
of radiobiology: 
Repair – repair of sublethal damage is temperature dependent and is thought 
to represent the enzymatic mechanisms responsible for intracellular injury healing; 
Re-oxygenation – after radiation exposure in a tumor, oxygen and other 
nutrients are actually better distributed to viable cells; 
Repopulation – cell population enhances cellular divisions in order to replace 
dying and dead cells; 
Redistribution – the proportion of cells in different stages of the cell cycle is 
altered, due to the variability of cells’ radio-sensitivity over the cell cycle. 
These mechanisms are responsible for reversing some of the radiation effects: in some 
cases cells are capable to repair some if not all damage, continuing to function normally. 
However, in some cases, the damage is too serious, leading to cell death; in this case, radiation 
must produce double-strand breaks in DNA. In other cases, however damaged, cells continue 
dividing; in this case, daughter cells may in turn die or also continue to divide without full 
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repair of the radiation lesion, perpetuating mutations which may lead to malignant tumor cell 
lines. Oxygen saturation is other important factor of sensitivity, as high levels of tissue and 
cellular oxygen increase the amount of reactive oxygen species produced. 
Gray (Gy) is the SI unit of absorbed radiation dose and is defined as the amount of 
energy (Joules, J) absorbed by one kilogram (Kg) of matter; other important units are listed in 
Table 8. The main effects of radiation depend upon the absorbed dose and the length of 
exposure, therefore acute and chronic effects are defined.  
Table 8 - Units and Definitions (Modified from (Harrison's 2005)) 
Unit Quantity Measured Definition 
Roentgen (R) Exposure Amount of x-rays or gamma rays 
that produce 2 × 10
9 
pairs of ions in 
1 cm
3 
of air at 0:C. 
Curie (Ci) Radioactivity Number of disintegrations per 
second in 1 g of 
226
Ra. 
Becquerel (Bq) Radioactivity Amount of disintegrations per unit 
of time in any radioactive specie. SI 
unit. 
Rad Dose 100 ergs deposited per gram of 
tissue or 0.01 J per kilogram of 
tissue. 
Gray (Gy) Dose Amount of energy per unit of mass. 
(1 J/Kg). SI unit. 1 Gy = 100 rad. 
Roentgen equivalent in men (Rem) Dose equivalence Reflects biologic response. Used to 
compare various types of radiation. 
Sievert (Sv) Dose equivalence SI unit of dose equivalence; 1 Sv 
=100rem. 
Acute and Chronic Effects 
Acute effects occur by exposure to high doses of radiation in a small length of time, 
normally leading to a shortening of the life expectancy of the irradiated organism. Cell radio-
sensitivity depends on the targeted organelle (nucleus, for instance, is more sensitive than 
cytoplasm) and the cell cycle phase (chromosome abnormalities typically occur in cells 
irradiated in the G1 phase; if cells are irradiated in the G2 phase, chromatid aberrations are 
more likely to result) and . Chromosomal abnormalities and mutations may lead to cell cycle 
alteration, cell death or malignant transformation. DNA radiation effects include base linkage 
alteration, base replacement (transversions or transitions); single and double strand breaks, 
which may induce mitosis inhibition or mitotic arrest, among other effects. Radiation-induced 
chromosomal modifications can be detected in metaphase.  
When organisms suffer acute exposure, the clinical outcome can be classified in one of 
three radiation syndromes: Gastrointestinal (GI), Hematopoietic and Central Nervous System 
(CNS) syndrome. In the GI syndrome intestinal lumen cells lesions, dehydration, weight loss 
and serious infections may be present. In the Hematopoietic syndrome the most affected 
tissues are those responsible to blood cell production, causing anemia (erythrocytes loss) and 
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systemic infections (leukocytes loss). Efficiency of medical treatment increases when total 
doses are below 10 Gy.  
Chronic effects occur in low dose exposures over long period of time. High doses tend 
to kill cells, damaging tissues and organs, while low doses tend to transform them: 
consequently, high doses usually trigger fast body response, while low doses interact at 
cellular level, and their results may be observed some time after cumulative exposure. 
On chronic exposures we may also identify three types of effects: somatic effects, 
where only directly irradiated cells are affected, cancer being the major consequence; gonadal 
effects, where reproductive line cells are irradiated, potentially transmitting abnormalities to 
generations to follow; and in-utero effects, due to radiation exposure during gestation. In 
addition to these classical targeted effects of ionizing radiation, intense research activity has 
been focused recently on non-targeted IR effects, including genomic instability, adaptive 
response and bystander effects.  
Radiation exposure increases the mutation rate, not the variety of types of mutations. 
Radio-induced cancers are similar in everything to spontaneous cancers, making it difficult to 
pin-point radiation as the underlying cause of a given cancer; however several large scale 
epidemiological studies have associated chronic radiation exposure to leukemia or thyroid, 
bone, lung, breast, skin cancers. 
Radiation may also cause several fetus development damages: in-utero effects. 
Growing embryo is very sensible to radiation because it is made of very fast dividing cells with 
oxygen rich blood supply. In-utero death, congenital abnormalities, growth and development 
deficiencies and childhood cancers are major effects of in-utero exposure. Radiation damages 
depend upon fetus development stage. In terms of skin response to irradiation, an acute 
reaction can be seen after two weeks post exposure, and this latency can be correlated with 
the time required for cells to move from the basal to the keratinized layer of the skin. Skin 
reaction is characterized by erythema followed by dry desquamation and, sometimes, by 
edema. The vessels in the upper dermis are dilated and inflammatory infiltration is noted. 
Chronic skin reaction can be seen starting 6 to 12 months after irradiation. Skin 
atrophy may occur resulting in higher sensitivity to injury than in normal skin. Interstitial 
fibrosis and telangiectasia (small dilated blood vessels near the surface of the skin or mucous 
membranes) may also be increased. Hyperpigmentation can be seen after a few months, 
fading gradually. The skin becomes thin and hair loss may be permanent. Radiation therapy 
can induce second malignancies, tending to be more aggressive than original cancers not 
related to radiation exposures. 
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Melanin 
The group of compounds known as melanin comprises a class of tyrosine derivate 
compounds present in most living organisms, predominantly serving as high molecular weight 
pigments. Two most common forms of biological melanin are eumelanin and pheomelanin, 
considered to make up the mixed melanosomal melanin polymer present in human hair and 
skin. Microscopically, melanin is brown, non refractive and finely granular, with a diameter of 
less than 800 nm. Melanin is not soluble in water, but can be diluted in some organic solvents.  
Types and Biosynthesis of Melanin 
Eumelanin is a brown-black polymer of 5,6-dihydroxyindole (DHI), 5,6-dihidroxyindole-
2-carboxylic acid (DHICA) monomer units, and their reduced forms. Pheomelanin is a red-
brown polymer of benzothiazine. The higher number of electrons in oligomers of pheomelanin 
relative to eumelanin (Figure 9) – 388 versus 287 – could result in better scattering properties 
of pheomelanin (Dadachova E 2007). However, pheomelanin appears to provide a lower level 
of protection against UV radiation and, moreover, it is considered a possible source of free 
radicals when irradiated with UV (Smit, et al. 1998). 
 
Fig. 9 – Chemical composition of melanin and its precursors: a) structure of eumelanin oligomer; b) structure of 
pheomelanin oligomer; c) L-Dopa; d) dopamine; e) L-tyrosine. (Howell, et al. 2008) 
The first step of the biosynthetic pathway for both major types of melanin is catalysis 
by tyrosinase: 
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Tyrosine → DOPA → Dopaquinone 
Dopaquinone can combine with cysteine by two pathways to produce benzothiazine 
and pheomelanin: 
Dopaquinone + cysteine → 5-S-cysteinyldopa → benzothiazine intermediate → pheomelanin 
Dopaquinone + cysteine → 2-S-cysteinyldopa → benzothiazine intermediate → pheomelanin 
Dopaquinone can be converted to leucodopachrome and follow two more pathways to 
be converted to eumelanin: 
Dopaquinone → leucopachrome → dopacrome → 5,6-dihidroxyindole-2-carboxylic acid → quinone 
→ eumelanin 
Dopaquinone → leucopachrome → dopacrome → 5,6-dihidroxyindole → quinone → eumelanin 
At the secondary structural level there is no generally accepted model of melanin 
polymers with this uncertainty resulting from the multiple binding configurations that 
functionalized indoles can adopt. Two most prevalent models of melanin structure are: 1) 
heteropolymeric model which postulates that the melanin polymer forms via random bonding 
between monomers; 2) stacked oligomer model which suggests that melanins are composed 
of stacked oligomeric "proto-molecules" consisting of no more than 5–6 indolequinone units 
(Howell, Schweitzer, et al., Chemosorption of radiometals of ineterest to nuclear medicine by 
synthetic melanins 2008). 
Melanogenesis 
The increased production of melanin in human skin is called melanogenesis, usually 
taking place in UV stimulated melanocytes. The photochemical properties of melanin make it 
an excellent photo protector, absorbing harmful UV radiation and converting its energy into 
harmless amounts of heat through a process called “ultrafast internal conversion”. This 
property enables melanin to dissipate more than 99,9% of absorbed UV radiation as heat and 
keeps free-radical formation at minimum. The photoprotective properties of the pigment 
melanin and its precursors in cultured melanocytes or melanoma cells have been the subject 
of many studies (Smit, et al. 1998). Photoprotection by melanin is still a matter of 
investigation. The situation is complex because the composition as well as the quantity of the 
melanin in the skin is of importance for photoprotection or photosensitization. Elevated 
melanin production is connected to the risk of oxidative imbalance, may leading to mutations 
and provides a basis for malignant transformation of pigment cells (Smit, et al. 2008). 
Hazardousness of melanin synthesis 
As stated above, melanin is often considered to be a protective polymer because it 
absorbs UV radiation and scavenges diverse radicals. However, the production of this pigment 
involves oxygen-dependent generation of reactive ortho-dihydroxyindoles and –phenols and 
their respective (semi)quinones that polymerize with each other forming a polymer network 
(Smit, et al. 2008), and so melanin production is also considered as a potential (geno)toxic 
threat to melanocytes since different melanin precursors, formed during melanogenesis, 
exhibit high reactivity (ROS and other reactive molecules). Thus, the compartmentalization of 
melanogenesis by means of membrane-limited melanosomes has been postulated to be of 
great importance for the self-protection of cells (Smit, et al. 1998). However, Pheomelanin 
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synthesis consumes cysteine, limiting anti-oxidative defense. Recently it has been shown that 
these nevi synthesize more pheomelanin than do normal skin melanocytes (Smit, et al. 2008). 
As mentioned above, this metabolic disturbance can make them predisposed to oxidative 
stress. 
Gamma Radiation Interaction with Melanin 
The number of electrons per gram is an important contributor to the attenuation 
properties of a material at the energy levels where the Compton effect predominates 
(Dadachova E 2007). Compton scattering predominates for chemical elements with low atomic 
numbers such as C, N, O and S, which constitute melanin. In the Compton scattering, transfer 
of photon energy to matter occurs via a cascade of interactions, where the energy of the 
incident photon is transferred to high-energy electrons, and to secondary photons of 
progressively lower energy until the photoelectric effect takes place. Thus, the existence of 
structures composed of electron-rich, covalently linked aromatic motifs could explain the 
radiation scattering properties of melanins.  
The high-energy electrons generated by Compton scattering are ultimately responsible 
for the biologic effects of gamma radiation by either direct interaction with DNA or through 
radiolysis of water in the cells, a process that results in the formation of reactive short-lived 
free radicals capable of damaging DNA. Melanin may interact with these high-energy electrons 
and prevent them from entering a cell, thus enabling its function as a radioprotector. The 
Compton electrons may then undergo secondary interactions with other melanin molecules, 
having their energy gradually lowered by melanin (Dadachova E 2007). 
Protective role of melanin 
Melanin is the primary determinant of human skin color and also found in hair, 
pigmented tissue underlying the iris, medulla and zona reticularis of the adrenal gland, stria 
vascularis of the inner ear and in pigmented-bearing neurons within areas of the brain stem, 
such as the locus cereleus and substancia nigra pars compacta. As previously stated, dermal 
melanin is produced by melanocytes, located in stratum basale of epidermis (Fig. 10). 
Melanocytes comprise from 5% to 10% of the cells in the basal layer of epidermis and are 
typically 7 μm in length. Although all human beings generally possess a similar amount of 
melanocytes in their skin (between 1000 and 2000 melanocytes per mm2 of skin), the 
melanocytes in some individuals and ethnic groups more or less frequently express the 
melanin-producing genes, conferring greater or lesser concentration of skin melanin. In vivo, 
normal melanocytes transfer their melanosomes to keratinocytes lowering their own risk of 
oxidative stress (Smit, et al. 2008); melanin granules are transferred from melanocytes to 
keratinocytes in specialized vesicles called melanosomes. Melanosomes in each recipient 
keratinocyte cell accumulate atop the cell nucleus, protecting nuclear DNA. Molecular 
mechanism of melanin at cellular and sub-cellular level is not yet fully explained by 
biophysical and biochemical studies (Ghannam 2003). 
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Fig. 10 - Skin structure and melanocyte localization in stratum basale of epidermis. (web-books.com 2009) 
Melanins present numerous interesting physico-chemical characteristics including 
electromagnetic radiation absorption properties and the ability to chelate metals (Howell, et 
al. 2008). A recent study (Dadachova E 2007) showed evidences for radio-resistance in 
melanized fungi. These melanized fungal species colonize the walls of the highly radioactive 
reactor at Chernobyl and surrounding soils, often being dominant species in this kind of 
extreme environments and suggesting a role for melanin in radioprotection. In this work we 
hypothesized that an alteration in the melanin electronic properties alterations may occur due 
to radiation interactions that this may enhance the growth of melanized micro-organisms. 
Irradiated melanin manifests a 4-fold increase in its capacity to reduce NADH relative to non-
irradiated melanin. It was found that also non-ionizing forms of radiation, infrared (IR), visible 
and UV light, increased the ability of melanin to transfer electrons, being independent of the 
energy of the incident photons (Table 9). 
Table 9 - Increase in electron-transfer properties of melanin in NADH reduction after exposure to different forms 
of electromagnetic radiation (Dadachova E 2007)  
Radiation Type Photon energy, eV Increase in initial velocity in 
NADH reduction 
Ionizing radiation from 
137
Cs 
source 
661 000 4.0 
UV, 254 nm 4.7 3.9 
Visible light, 250 W 3 4.0 
Heat, 348.15 K 0.1 3.7 
 
To obtain additional evidence that exposure to ionizing radiation enhanced cell 
growth, Dadachova, et al. measured the incorporation of 14C-labed acetate into melanized and 
non-melanized C. neoformans (fungi) cells with and without radiation flux. There was no 
incorporation of 14C-acetate into heat killed melanized or non-melanized cells, which excludes 
the possibility that radiation promoted the passive absorption of 14C-acetate on melanin. There 
was almost 3 times more incorporation of 14C-acetate into irradiated melanized cells than into 
non-irradiated cells. These results demonstrate that the presence of melanin contributes to 
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the enhancement of cellular growth upon exposure to ionizing radiation in conditions of 
limited nutrients, because irradiated melanized cells experienced growth enhancement even in 
starvation conditions (Figure 11).  
Radiation-induced effects on the electron-transfer properties of melanin were 
localized to the extracellular space thus establishing a spatial relationship between the site for 
electron-transfer events and the location of the melanin pigment. The ability to capture 
electromagnetic radiation and redox properties may confer melanized organisms with the 
ability to harness for metabolic energy (Dadachova E 2007). 
 
Fig. 11 - Microscopic images of melanized fungal cells: a) light microscopy image of C. neoformans melanin 
‘‘ghosts’’; (b–e) TEM images of C sphaerospermum ‘‘ghosts’’ derived from cells grown on nutrient rich or 
nutrient-deficient media: b) potato dextrose agar; c) Sabaroud dextrose agar; d) water agar with casein; e) water 
agar with dextrose. Original magnification: light microscopy image – X 1,000; TEM images – X 13,000 (Dadachova 
E 2007). 
Recent research (Liu, et al. 2004) suggest that melanin is able to chelate metal ions 
through its carboxyle and phenolic hydroxyl groups, in many cases much more efficiently than 
ethylenediaminetetraacetate (EDTA). This hypothesis is supported by the fact that the loss of 
neuromelanin observed in Parkinson’s disease is accompanied by an increase in iron levels in 
the brain. Howel et al. demonstrated that synthetic melanins made of diverse precursors can 
chemosorb 111In, 213Bi and 225Ac radioactive metals with dopamine, L-dopa and tyrosine 
melanins being the most efficient. This property may be useful in bioremediation strategies 
whereby melanized microorganisms such as bacteria or fungi are potentially used to collect 
and immobilize heavy metals pollutants (Howell, et al. 2008).  
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These properties could also find an application in protecting bone marrow or 
gastrointestinal tract of cancer patients undergoing external beam radiation therapy (EBRT) or 
persons contaminated internally with radionuclides by administering melanin systemically in 
form of nanoparticles or powders. The advantage of synthetic melanin over other 
radioprotectors or metal chelating agents is its complete chemical inertness (Howell, et al. 
2008). 
In vitro melanin production 
Smit, et al. 1998, performed an evaluation of the influence of different culture media 
on pigment production. With higher L-tyrosine concentrations in the medium, 
pheomelanogenesis as well as increased eumelanin synthesis were stimulated in all cultures 
tested. This stimulation was particularly prominent in type I (pale white skin, blue/hazel eyes, 
blond/red hair individuals) skin melanocytes than type IV (light brown skin individuals) skin 
melanocytes. 
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Fig. 12 - TEM showing the microscopic pigmentations phenotypes of melanocytes: a) skin type I in vitro (bar 1.15 
μm); b) skin type IV in vitro (bar 0.17 μm); c) skin type I in vivo (bar 0.17 μm); d) skin type VI  in vivo (bar 0.12 μm) 
(Smit, et al. 1998). 
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Cell Line and Culture 
Cell Line 
B16-F1 mouse melanoma cells, with melanin producing capability, were used in this 
work. This cell line has an adherent growth pattern and fibroblast-like morphology (Fig. 13 
left).  
 
Fig. 13 - B16-F1 cell culture (left) – image acquired with Motic AE21 inverted microscope (400X) (right) and 
Cannon Powershot A620 Digital Camera 
Culture medium 
The base medium for cell growth was Dulbecco’s Modified Eagle’s Medium with L-
glutamine (DMEM D5648, Sigma Aldrich, St. Louis, MO) supplemented with 10% Foetal Bovine 
Serum (FBS) and 1% antibiotics (penicillin and streptomycin). 
Cell culture and subculture routine 
The cell culture was conducted in T75 CellStar® Greiner Bio-One culture flasks, with 
subculture density of 1 ml cell suspension to 9 ml of supplemented DMEM medium (10 ml 
total volume), kept at 37oC temperature, 5% carbon dioxide humidified atmosphere. When 70 
– 80% confluence was reached subcultures where performed by removing medium, washing 
with phosphate-buffered saline (PBS), adding 1 ml trypsin-EDTA solution (0.25% trypsin, 0.53 
mM EDTA), after which the cells were allowed to detach by sitting the flask sits at 37oC for a 
few minutes, followed by adding 9 ml of fresh culture medium with FBS (which contains 
trypsin inhibitors). 1 ml of the cell suspension was dispensed into a new culture flask (as 
detailed above) and medium was renewed every 3 days. 
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Irradiation Equipment 
The irradiation equipment, a high activity gamma AECL ELDORADO 6 irradiator (60Co 
92.5 TBq source) (Fig. 14), was part of the Metrological Laboratory of Ionizing Radiation and 
Radioactivity of the Technological and Nuclear Institute. 
 
Fig. 14 - AECL ELDORADO 6 Irradiator high activity 
60
Co 92.5 TBq source. 
For the irradiation procedure a 10x10 cm field at 1 m from the source was used (Fig. 14 
right). The dose rate at this distance was 0.1099 Gy/min. For example, for an exposure dose of 
1.5 Gy, the length of irradiation was 13.65 min (Fig. 15 left).  
 
Fig. 15 - Left: Irradiator command unit. Right: Environmental dose equivalent monitor performs readings inside 
irradiation bunker. 
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Biomarkers for Genotoxicity (CBMN 
assay) 
The in vitro cytokinesis-blocked micronucleus assay (CBMN assay) is a genotoxicity test 
system based on the detection of micronuclei (MNi), small inclusions of DNA material, in the 
cytoplasm of interphase cells. These MNi may originate from acentric fragments or whole 
chromosomes that are unable to migrate with the remaining chromosomes during the 
anaphase of mitosis due to structural alterations caused by exposure to mutagenic and 
genotoxic physical and chemical agents (OECD 2006). At telophase, a nuclear envelope forms 
around chromosomes and fragments, which then uncoil and gradually assume the morphology 
of an interphase nucleus with the exception that they are smaller, hence the term 
“micronucleus” (Fenech 2000). 
The micronucleus assay has emerged as one of the preferred methods for assessing 
chromosome damage because it allows for the reliable detection of both aneuploidy 
(chromosome loss) and chromosome or chromatid breakage. Because MNi are only expressed 
in cells that complete one nuclear division after damage, a special method was developed that 
identifies recently divided cells by their binucleated (BN) appearance when blocked from 
performing cytokinesis using cytochalasin-B (Cyt-B), a microfilament-assembly inhibitor. The 
CBMN assay presents a good reproducibility, as the results obtained are not biased by 
potentially altered division kinetics caused by direct cytotoxicity of the agents tested or by sub-
optimal cell culture conditions. The method is now applied for specific purposes in 
radiobiology, such as the prediction of the radiosensitivity of tumors and the inter-individual 
variation in radiosensitivity (Fenech 2000). 
The CBMN assay has a number of advantages over metaphase analysis used to score 
chromosomes aberrations, as described in the OECD Guidelines 473 and 475 (OECD 2006). 
Because MNi in interphase cells can be assessed more objectively than chromosomal 
aberrations in metaphase cells, a less detailed training is required for testing personnel to 
achieve competence. In the CBMN there is no need to count the chromosomes as in 
metaphase preparations, but only to determine whether or not the cells contain micronucleus. 
As a result, there is a significant increase in throughput of scoring, with positive impact in the 
statistical power of the study, given that thousands instead of hundreds of cells can be scored 
per treatment (OECD 2006). 
Chromosome breaks may arise from unrepaired double strand breaks in DNA. It is also 
recognized that chromosome partial or total loss, aneuploidy and non-disjunction are 
important events in cancer and they are probably caused by defects in the spindle, centromere 
or as a consequence of under-condensation of chromosome structure before metaphase 
(Fenech 2000). Therefore, the mechanism that causes the increased frequency of MNi is 
directly implicated in the carcinogenic pathway. 
Because MNi are only expressed in cells that have completed nuclear division, they are 
ideally scored in the BN stage of the cell cycle. Occasionally nucleoplasmic bridges between 
nuclei in BN cell are observed. These are probably dicentric chromosomes in which the two 
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centromeres were pulled to opposite poles of the cell and the DNA in the resulting bridge 
covered by nuclear membrane (Fig 16) (Fenech 2000). 
 
Fig. 16 a) - The origin of MNi from lagging whole chromosomes and acentric fragments during anaphase. b) - The 
formation of nucleoplasmic bridge from a dicentric chromosome. The critical role of Cyt-B in blocking dividing 
cells at the BN stage is also indicated in this diagram (Fenech 2000). 
The method was initially developed for use with cultured human lymphocytes, but has 
now been adapted to various cell types such as solid tumors. The most critical points of the 
method are: 
a) Analyzing exclusively BN cells to ensure that MNi are scored in the first nuclear 
division following the irradiation; 
b) Allowing sufficient time for Cyt-B to act: it takes up to 6h before it starts to 
exert its cytokinesis-blocking action. 
Criteria for selecting BN cells which can be scored for MNi 
frequency 
The cells that may be scored for MNi frequency should have the following 
characteristics (Fenech 2000): 
a) The cells should be BN; 
b) The two nuclei in a BN cell should have intact nuclear membranes and be 
situated within the same cytoplasmic boundary; 
c) The two nuclei in a BN cell should be approximately equal in size, staining 
pattern and intensity; 
d) The two nuclei within a BN cell may touch, but ideally should not overlap each 
other. A cell with two overlapping nuclei can be scored only if the nuclear 
boundaries of each nucleus are distinguishable; 
e) The two nuclei within a BN cell may be attached by a fine nucleoplasmic bridge 
which is no wider than 1/4th of the nuclear diameter; 
f) The cytoplasmic boundary or membrane of a BN cell should be intact and 
clearly distinguishable from the cytoplasmic boundary of adjacent cells. 
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Fig. 17 a) ideal BN cell; b) BN cell with touching nuclei; c) and d) BN cells with nucleoplasmic bridge 
(Fenech 2000). 
Examples of the type of BN cells that may be scored are illustrated in Fig. 17. The cell 
types that should not be scored for MNi frequency include mono-, tri-, tetra- and multi-
nucleated cells, and cells that are apoptotic or necrotic (Fig. 18) 
 
Fig. 18 - The various types of cells that may be observed in the in vitro CBMN assay excluding BN cells. These cell 
types should not be scored for MNi frequency (Fenech 2000). 
Criteria for scoring MNi 
MNi are morphologically identical to, but smaller than, nuclei. They also have the 
following characteristics (Fenech 2000): 
a) The diameter of MNi usually varies between 1/16th and 1/3rd the mean 
diameter of the main nuclei which corresponds to 1/256th and 1/9th the area of 
one of one of the main nuclei in a BN cell, respectively; 
b) MNi are non-refractive and they can therefore be readily distinguished from 
artifacts such as particles of staining reagent; 
c) MNi are not linked or connected to the main nuclei; 
d) MNi may touch but not overlap the main nuclei and the micronuclear 
boundary should be distinguishable from the nuclear boundary; 
e) MNi usually have the same staining intensity as the main nuclei but 
occasionally staining may be more intense. 
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Fig. 19 a) Cell with two MNi, one with 1/3
rd
 and the other 1/9
th
 the diameter of one of the main nuclei within the 
cell; b) MNi touching but not overlapping the main nuclei; c) A BN cell with nucleoplasmic bridge between the 
two main nuclei and two MNi; d) A BN cell with six MNi of various sizes (Fenech 2000). 
Examples of typical MNi that meet the criteria set above are shown in Fig. 19. 
Examples of cellular structures that resemble MNi but should not be classified as MNi 
originating from chromosome breakage or loss are illustrated in Fig. 20. 
 
Fig. 20 Occasionally BN cells (or cells that resemble BN cells) may contain structures that resemble MNi but 
should not be scored as MNi originating from chromosome loss or chromosome breakage. These situation 
include: a) a trinucleated cell in which one nucleus is relatively small but has a diameter greater than 1/3
 
the 
diameter of the other nuclei; b) dense stippling in a specific region of cytoplasm; c) extruded nuclear material 
that appears like a MNi with a narrow nucleoplasmic connection to the main nucleus and d) nuclear blebs that 
have an obvious nucleoplasmic connection with the main nucleus (Fenech 2000). 
 
Procedures and Results 
 
B16-F1 cells were subcultured in 5 cm diameter sterile Petri dish (1x105 cells each) 24h 
before irradiation procedure. At 44 h of incubation, cytochalasin-B was added to the culture 
medium. At the end of incubation, cells were harvested by trypsinization, centrifuged, washed 
with washing solution twice and submitted to a mild hypotonic shock to enlarge the cytoplasm 
of the cell and improve scoring. The cells are then smeared onto clean glass slides, allowed to 
dry, fixed, and stained by Giemsa (complete protocol in Appendix 2, Protocol 1). All 
calculations were performed using MicrosoftTM Excel 2007 or manually. Slides were scored in 
an optical transmitted light Carl-Zeiss D-7082 Oberkochen microscope, slide scanning at 250X 
magnification and MNi confirmation at 400X magnification. 
For choosing a gamma radiation dose, dose-response screening experiments were 
performed at 0, 0.5, 1, and 2 Gy. Results are listed in Table 10 and depicted in Fig. 21 chart. 
After analysis of the results, an interpolated irradiation dose of 1.5 Gy was chosen to 
obtain an adequate significance for the different melanin concentration assays. 
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Table 10 – CBMN assay micronuclei frequency at 0, 0.5, 1.0 and 2.0 Gy 
Dose 
(Gy) 
Mono-micronucleated cells Poly-micronucleated cells Total micronucleated cells 
Mean SD Mean SD Mean SD 
0.0 2,000 1,414 0,000 0,000 2,000 1,414 
0.5 12,000 0,000 2,000 0,000 14,000 0,000 
1.0 15,667 7,095 1,667 0,577 17,333 6,658 
2.0 51,000 15,556 12,500 0,707 63,500 14,849 
 
 
Fig. 21 – CBMN assay micronuclei frequency at 0, 0.5, 1 and 2 Gy chart. 
Because melanin is insoluble in water, a 10 g/l melanin-DMSO solution was made. In 
early experiments, higher concentrations of melanin were also tested, however a solubilisation 
problem was verified when the melanin-DMSO solution was added to the cells and so melanin 
was kept at stably soluble levels in the final media. 
Different synthetic melanin (Sigma-Aldrich, St Louis USA) concentrations added to the 
cell culture were irradiated at 1.5 Gy Non-irradiated cells were used as control. Results of MNi 
quantification after irradiation in the presence of different melanin concentrations are listed in 
Table 11 and depicted in Fig. 22 chart. 
Table 11 – CBMN assay micronuclei frequency in B16-F1 cells irradiated at 1.5Gy of gamma radiation in the 
presence of different concentrations of melanin added in medium. Non-irradiated cells were used as control. 
Melanin 
Concentration 
g/l 
Monomicronucleated 
cells 
Polimicronucleated 
cells 
Total micronucleated 
cells 
Mean SD Mean SD Mean SD 
Control cells 2,00 1,41 0,00 0,00 2,00 1,41 
0,02 99,00 8,75 23,60 5,22 122,60 11,30 
0,10 85,50 5,45 18,25 2,87 103,75 7,80 
0,20 61,80 13,77 11,40 3,91 73,20 17,47 
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Fig. 22 - CBMN assay micronuclei frequency in B16-F1 cells irradiated at 1.5Gy of gamma radiation in the presence 
of different concentrations of melanin added in medium; non-irradiated cells were used as control(*) p<0.05 
between different melanin concentrations and compared to control (Student’s t-test). 
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Fig. 23 - Examples of binucleated (BN) cells observed in the slides. Top left – BN cell without micronuclei (MNi). 
Top center, top right, middle left and middle center – BN cells with one MNi. Middle right and bottom – BN cells 
with more than one MNi. Images obtained using an optical transmitted light Carl-Zeiss D-7082 Oberkochen 
microscope (400x magnification) and Canon Powershot A620 digital camera. 
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Acute Cytotoxicity – MTT Assay 
This method is a simple quantitative assay to determine the cellular viability in 
samples, by analyzing the capacity of cells to metabolize MTT in a mitochondria-dependent 
reaction, producing a colored compound, formazan, to which the cell membrane is 
impermeable. 
The tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) is taken into cells and reduced by mitochondrial succinic dehydrogenase activity to yield 
a purple formazan product (Ibelgaufts 2008). Chemical structures of substrate and final 
compound are presented in Fig. 24. The product accumulates within the cell, due to the fact 
that it cannot pass through the plasma membrane. Upon cell membrane disruption by organic 
solvents, the product is released and can be readily detected and quantified in the supernatant 
by a UV/Visible spectrophotometry. 
 
Fig. 24 – Structures of MTT tetrazolium and formazan (Scudiero, et al. 1988). 
The ability of cells to reduce MTT provides an indication of mitochondrial integrity and 
activity which, in turn, may be interpreted as measure of viability and/or cell proliferation. 
Determination of cellular ability to reduce MTT to formazan after exposure to a toxic 
aggression, when compared to control samples provides a measure of the relative toxicity 
experienced by the cells under exposure conditions (Mosmann 1983). 
Procedure and Results 
Cultured B16-F1 cells were plated into 96-well flat bottom microplates with different 
synthetic melanin (Sigma-Aldrich, St Louis USA) concentrations added to the media, incubated 
for 24 h and irradiated at 1.5 Gy exposure dose. 24h post-irradiation the cells were exposed to 
MTT during 4h, after which 200µL of DMSO were added to each well to disrupt cell 
membranes and extract the formazan into the supernatant. The amount of solubilized 
formazan product in each well was determined using a Rosys Anthos 2010 microplate reader 
spectrophotometer (Fig 25), with readings performed at 540 nm and using 620 nm as 
reference wavelength (see complete protocol in Appendix 2, Protocol 2). The amount of 
formazan present in exposed samples conditions was expressed as a percentage of that 
occurring in the control samples, as follows: 
% 𝑐𝑒𝑙𝑙 𝑠𝑢𝑟𝑣𝑖𝑣𝑎𝑙 =  
𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑐𝑒𝑙𝑙𝑠
× 100 % 
Radiobiology of Malignant Melanoma 
- 62 - 
 
Uncertainty of measurement was calculated using uncertainty propagation method 
(see appendix 1: data analysis – uncertainty propagation) which gave the expression: 
𝜎𝑐𝑠
2 =  
1
𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑐𝑒𝑙𝑙𝑠
 
2
𝜎𝐴
2 
Where 𝜎𝑐𝑠
2  is the variance in cell survival and 𝜎𝐴
2 is the variance in absorbance 
measurements. All calculations were performed using MicrosoftTM Excel 2007 and/or manual 
methods. 
 
Fig. 25 - Rosys Anthos 2010 microplate reader spectrophotometer. 
Results at different melanin concentration are listed in Table 12 and depicted in Fig. 26 
chart. 
Table 12 – MTT assay results in B16-F1 cells irradiated at 1.5Gy of gamma radiation in the presence of different 
concentrations of melanin added in medium.  𝝈𝑨 is the standard deviation in absorbance measurements and 𝝈𝒄𝒔 
is the standard deviation in cell survival. 
Doses 0 Gy 1,5 Gy 
Melanin 
Concentration 
(mg/ml) 
0 0 0,1 0,15 0,2 0,5 
Absorbance 
Mean 
0,247 0,177 0,224 0,294 0,357 0,482 
σA 0,038 0,023 0,047 0,071 0,050 0,043 
% Cell Survival 100% 72% 91% 119% 145% 195% 
σCS 16% 9% 19% 29% 20% 17% 
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Fig. 26 – MTT cell survival results in B16-F1 cells irradiated at 1.5Gy of gamma radiation in the presence of 
different concentrations of melanin added in medium. (*) p<0.05 compared to control (Student’s t-test). 
 
The previous experiments were focused on the effects of extracellular melanin 
concentration in radiation damage. In order to investigate the pattern of melanin modulation 
of radiation damage with different intracellular concentrations of melanin B16-F1 cells were 
incubated in Ham F10 media (Sigma-Aldrich, St Louis USA), with low and high concentration of 
melanin precursor, tyrosine. Hams F-10 medium was chosen for its low L-tyrosine content.  
Final concentrations used were the following:  0.01 mM concentration of L-tyrosine (1T- 0.01 
mM tyrosine in the original Ham´s F-10 medium) and 40 times that concentration of L-tyrosine 
(40T – 0.4 mM) as described by Smit, et al. 1998. Results of MNi assay after 1.5Gy irradiation in 
cells grown in the different melanin concentrations are listed in Table 13 and depicted in Fig. 
27 chart. 
Table 13 - MTT assay results in B16-F1 cells irradiated at 1.5Gy of gamma radiation for 1T and 40T L-tyrosine 
concentrations in culture medium. 𝝈𝑨 is the standard deviation in absorbance measurements and 𝝈𝒄𝒔 is the 
standard deviation in cell survival. 
Dose 0 Gy 1,5 Gy 
Culture Media 1T 1T 40T 
Absorbance 
Mean 
0,259 0,224 0,228 
σA 0,047 0,049 0,048 
% Cell Survival 100% 86% 88% 
σCS 18% 19% 19% 
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Fig. 27 - MTT assay results in B16-F1 cells irradiated at 1.5Gy of gamma radiation for 1T and 40T L-tyrosine 
concentrations in culture medium. No statistical significant differences were found between the groups. 
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Oxidative Stress determination – MDA 
quantification 
Oxidative stress generates reactive oxygen species (ROS) that can interact with 
phospholipids and fatty acids to generate many reactive products including aldehydes. This 
process is commonly referred to as lipid peroxydation. Of the many biological targets of 
oxidative stress, lipids are the most involved class of biomolecules. Lipid peroxydation gives 
rise to a number of secondary products, which perpetuate the cascade of oxidative These 
products are mainly aldehydes, with the ability to exacerbate oxidative damage due to the 
longevity and high reactivity of  these molecules, allowing them to act inside and outside the 
cells, interacting with critical biomolecules such as nucleic acids and proteins, often irreversibly 
damaging the delicate mechanisms in cell functionality (Del Rio, Stewart and Pellegrini 2005). 
Although lipid peroxidation occurs under normal physiological conditions, it becomes 
significant during viral and bacterial infection, xenobiotic and radiation exposure, and 
inflammation (Feng, et al. 2006). 
Malondialdehyde (MDA) is a major product of lipid peroxidation, being the principal 
and most studied product of polyunsaturated fatty acid peroxidation (Del Rio, Stewart and 
Pellegrini 2005); it not only reacts with cellular nucleophiles but also leads to self condensation 
to form MDA oligomers (Marnett 2002). MDA first shown to be carcinogenic in 1972 following 
topical administration to mice. This was an unusual result because the tumors arouse in a very 
short time and were not the type of tumors typically seen in a mouse skin assay (Marnett 
1999). Most assays to determine MDA have been developed on the basis of its derivatization 
with thiobarbituric acid (TBA). The condensation of these two molecules gives rinse to form a 
complex that can be quantified by spectrophotometry and fluorimetry (Del Rio, Stewart and 
Pellegrini 2005). Nevertheless, this reaction is not specific of MDA, since other compounds 
(other aldehydes, bilirubin) can react with thiobarbituric acid, and other chromophores 
present in the biological samples may absorb or fluoresce in the same wavelengths as the 
MDA-TBA complex. In an attempt to overcome this limitation, the TBA-MDA complex is 
extracted from the reaction mixture with an organic solvent, and the quantification is made 
using this extract (Goulart de Medeiros 2003). 
Procedures and Results 
Quantification of TBA reactive substances was based on the technique described by 
Dousset et al. (1983), with modifications. TBA reagent was added to triplicate samples of post-
irradiation (2-3 hours after irradiation) cell supernatant and heated at 100ºC for 10 minutes in 
order to favor the formation of the complex. Butilhydroxytoluene (BHT) was added to the 
reaction medium to avoid oxidation of lipids in the sample and the production of MDA artifacts 
during the 100ºC incubation. The complex was extracted from the aqueous phase by a fixed 
volume of 1-butanol, and the fluorescence of the organic solution was measured. A calibration 
curve was prepared using tetramethoxipropane (Fluka AG, Buchs Switzerland), which 
hydrolyses to MDA in water (see detailed protocol in Appendix 2, Protocol 3) (Goulart de 
Medeiros 2003). For fluorimetry measurements a Shimadzo RF-5000 spectrofluorophotometer 
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was used (Fig. 28). All calculations were performed using MicrosoftTM Excel 2007 and manual 
methods. 
  
Fig. 28 – Shimadzo RF-5000 spectrofluorophotometer. 
In the first set of experiments, different synthetic melanin concentrations in media 
were used. Calibration curve results are listed in Table 14 and depicted in Fig. 29 chart. From 
these results a function was obtained by linear least square fitting method (see appendix 1: 
data analysis – linear least square fitting method), where 𝑓𝑙 corresponds to fluorescence and 
𝑠𝑐 to standard concentration, 𝜎𝑎  is the uncertainty of parameter 𝑎 and 𝜎𝑏  the uncertainty of 
parameter𝑏. The function obtained was inverted to obtain concentration in function of 
fluorescence. Uncertainty of measurement was calculated using the uncertainty propagation 
method (see appendix 1: data analysis – uncertainty propagation). MDA assay results for the 
different concentrations of added melanin are listed in Table 15 and depicted in Fig. 30 chart. 
Table 14 – Calibration curve results - MDA assay for different concentrations of melanin. SD is the standard 
deviation. 
Standard 
concentration (10-6 
mol/ml) 
Mean SD 
0,00 4,594 0,219 
0,25 24,140 1,552 
0,50 43,533 1,790 
1,50 118,932 1,453 
2,50 195,000 2,928 
 
𝑓𝑙 = 4.611 + 76.285𝑠𝑐 
𝜎𝑎  = 0.217 
𝜎𝑏 = 0.740 
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Fig. 29 - Calibration curve results - MDA assay for different concentrations of melanin. 
𝑠𝑐 =
𝑓𝑙 − 4.611
76.285
 
𝜎𝑠𝑐
2 =   
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𝜕𝑓𝑙
 
2
𝜎𝑓𝑙
2 =   
1
76.285
 
2
𝜎𝑓𝑙
2  
Table 15 – MDA assay results in B16-F1 cells irradiated at 1.5Gy of gamma radiation for different concentrations 
of melanin added in culture medium. 𝝈𝑺𝑪 is the standard deviation in standard concentration. 
Dose 
Melanin 
Concentration 
(mg/ml) 
Standard 
Concentration 
(10
-8
 mol/ml) 
𝝈𝒔𝒄 
0 Gy 0,00 24,457 1,400 
1.5 Gy 
0,00 28,008 1,037 
0,02 26,075 0,853 
0,10 25,124 0,725 
0,20 24,651 0,813 
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Fig. 30– MDA assay results in B16-F1 cells irradiated at 1.5Gy of gamma radiation for different concentrations of 
melanin added in culture medium. (*) p<0.01 between different melanin concentrations and compared to control 
(Student’s t-test). 
In order to investigate the pattern of melanin modulation for radiation damage with 
different intracellular concentrations of melanin, B16-F1 cells were incubated in Ham F10 
media (Sigma-Aldrich, St Louis USA), with low and high concentration of melanin precursor, 
tyrosine. Hams F-10 medium was chosen for its low L-tyrosine content.  Final concentrations 
used were the following:  0.01 mM concentration of L-tyrosine (1T- 0.01 mM tyrosine in the 
original Ham´s F-10 medium) and 40 times that concentration of L-tyrosine (40T – 0.4 mM) as 
described by Smit, et al. 1998.  Calibration curve results are listed in Table 16 and depicted in 
Fig. 31 chart.  
From these results a function was obtained by linear least square fitting method (see 
appendix 1: data analysis – linear least square fitting method), where 𝑓𝑙 corresponds to 
fluorescence and 𝑠𝑐 to standard concentration, 𝜎𝑎  is the uncertainty of parameter 𝑎 and 𝜎𝑏  
the uncertainty of parameter𝑏. The function obtained was inverted to obtain concentration in 
function of fluorescence. Uncertainty of measurement was calculated using uncertainty 
propagation method (see appendix 1: data analysis – uncertainty propagation). 
𝑓𝑙 = 8.389 + 83.015𝑠𝑐 
𝜎𝑎  = 0.0.483 
𝜎𝑏 = 0.991 
𝑠𝑐 =
𝑓𝑙 − 8.389
83.015
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Results at different melanin concentration are listed in Table 17 and depicted in Fig. 32 
chart. 
Table 16 - Calibration curve results - MDA assay for 1T and 40T L-tyrosine concentrations in culture medium. SD is 
the standard deviation. 
Standard Concentration (10
-6
 
mol/ml) 
Mean SD 
0,00 6,817 0,594 
0,25 30,312 0,944 
0,50 50,069 0,200 
1,50 130,345 2,478 
2,50 196,114 5,169 
 
 
Fig. 31 - Calibration curve results - MDA assay for 1T and 40T L-tyrosine concentrations in culture medium. 
Table 17- MDA assay results in B16-F1 cells irradiated at 1.5Gy of gamma radiation for 1T and 40T L-tyrosine 
concentrations in culture medium. 𝝈𝑺𝑪 is the standard deviation in standard concentration. 
Dose 
Tyrosine 
concentration in 
medium 
Concentration 
(10
-8
 mol/ml) 
𝝈𝒔𝒄 
0 Gy 1T 35,939 1,245 
1.5 Gy 
1T 39,845 1,390 
40T 36,482 0,876 
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Fig. 32- MDA assay in B16-F1 cells irradiated at 1.5Gy of gamma radiation for 1T and 40T L-tyrosine 
concentrations in culture medium. (*) p<0.05[A1] compared to control (Student’s t-test). 
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Discussion 
Melanins are amorphous, irregular polymeric pigments present in most living 
organisms, generally responsible for the pigmentation of surface structure. They are insoluble 
in aqueous solution and some organic solvents (Ghannam 2003). In this work a 10 g/l melanin-
DMSO solution was made.  Mouse melanoma cells (B16-F1) were exposed to gamma radiation 
in the presence of different concentrations of extracellular melanin (added to the medium) 
and intracellular melanin (melanogenesis induction by its precursor tyrosine). 
For choosing an irradiation dose, an initial dose-response study was performed. The 
endpoint chosen for the screening test was the cytokinesis blocked micronucleus (CBMN) 
assay, a measure of genotoxicity, was performed with irradiation doses of 0, 0.5, 1, and 2 Gy. 
The interpolated dose of 1.5 Gy was chosen for the remaining experiments because it provides 
an easily detectable effect, significantly different from un-irradiated control, while not 
relevantly inhibiting cell growth, allowing for the adequate quantification of melanin influence 
on radiation damage. 
The selected irradiation dose was used in all the subsequent experiments: intracellular 
and extracellular variations of melanin concentration were induced in control and irradiated 
cells, and several endpoints of radiation damage were applied: cell viability by MTT assay, a 
non-specific measure of acute toxicity, oxidative stress by the quantification of 
lipoperoxydation products, expressed as malondialdehyde (MDA), and genotoxicity by the 
frequency of micronuclei in cytokinesis blocked binucleated cells (CBMN assay).  
Differences in melanogenesis by using the different tyrosine concentration in media 
could be macroscopically observed (Fig. 33) by an obvious brown coloration of the supernatant 
on the 3rd day of culture in DMEM but no coloration in Ham’s F10 medium. 
 
Fig. 33 – Soft-pink color in 3 days 1T Ham’s F10 medium, dark-brown color in DMEM, consequence of B16-F1 
melanin production. 
The CBMN results show a significant decrease in the genetic lesion with increasing 
melanin concentration (all results significantly different from the control sample and from 
each other, p<0.05 Student’s t-test), thus justifying the protective effect of melanin presence, 
by reducing genotoxicity of the gamma radiation. This protection may be achieved by reducing 
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the interaction of radiation with the target cells, through a shielding mechanism, or acting as a 
buffer molecule that reduces the yield of reactive and radicalar species.  
MTT assay shows an increase in cell viability with increased melanin concentration, 
again pointing to a protective effect of melanin. This effect is marked in the melanin 
concentration range tested, with some overshoot of cell viability above the control sample 
values, which cannot exclude a possible presence of a non-specific confounding factor – 
potentially due to the absorbance of melanin itself, present in the supernatant medium. To 
obviate this problem, a reference wavelength was used, in an area of the visible spectrum 
where formazan does not absorb visible radiation, but melanin does (620 nm) and absorbance 
values at this wavelength were subtracted from the test wavelength (540 nm) absorbance 
(Matuszak and Wasilewska-Radwanska 2006): the dose-response trend remained unaltered, as 
it is shown. Also the protective effects of melanin are reproducible in all endpoints tested and 
so this is not an isolated finding. A subtle increase in cell viability was observed in 40T cells, 
although not statistically significant. 
MDA values showed the same trend of dose-response as the previously described 
endpoints, adding strength to the model of melanin protective behaviour against ionizing 
radiation. Increasing melanin concentrations, both added melanin and induced melanogenesis, 
significantly decrease the concentration of lipoperoxydation products in the supernatant of 
gamma radiation exposed cells (p<0.01, Student’s t-test) and therefore the level of oxidative 
stress experienced by the irradiated cells. In the melanogenesis induction experiments, the 
protective pattern was reproduced, with a strikingly significant decrease of lipoperoxydation 
products in the 40T medium irradiated samples, showing a level of oxidative stress not 
statistically different from control unirradiated cells. Considering that oxidative injury is 
regarded as a major pathway for ionizing radiation toxicity, melanin ability to counteract this 
effect is quite relevant in terms of radiation protection. In addition, results for 
lipoperoxydation assay are technically more likely to be over- rather than under-estimated: the 
specificity of the test based on MDA-TBA reaction is low, as TBA may react with several 
compounds other than MDA also derived from oxidation. Moreover, the treatment of 
biological samples to obtain the condensation product is usually carried out at high 
temperature (around 100oC) and may generate further oxidation with obvious overestimation 
of results (Del Rio, Stewart and Pellegrini 2005). To overcome this limitation, the TBA-MDA 
complex is extracted from the reaction mixture with an organic solvent (1-butanol), and the 
quantification is made using this extract. 
In summary, our integrated results strongly suggest that melanin plays an important 
role in protection against ionizing radiation. 
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Conclusions 
The main conclusion drawn from the present study is that melanin may have an 
important role as a radioprotector for ionizing as well as non-ionizing radiation in living cells. 
This property may find applications, for example, in protecting bone marrow or 
gastrointestinal tract of cancer patients undergoing external beam radiation therapy, or 
possibly even individuals contaminated internally with radionuclides, from harmful local and 
systemic effects of ionizing radiation. 
It is important to notice the remarkable capacity of melanin both to attenuate γ rays 
interaction by Compton Effect and, at same time, being capable of accept electrons of the 
resulting interaction, preventing hazardous secondary ionizations, and therefore further 
reducing oxidative stress in biological systems. 
Future perspectives include testing of normal melanocytes, which have normal 
apoptotic pathways and allow an evaluation of the induction of apoptotic pathways by ionizing 
radiation in the presence and absence of melanin. This study could not be performed with 
B16-F1 cells due to the altered apoptosis  
Because melanin is not soluble in aqueous solution, a future work could integrate a 
development of a delivery system capable of administering melanin systematically in form of 
nanoparticles such as nanospheres, stable in the water-based extracellular medium, in order 
to harvest melanin’s protective properties without a necessary absorption of melanin by the 
living tissues. This development would make animal experiments possible. Another interesting 
future work may be conducting experiments on melanin behavior in cells irradiated with other 
qualities of ionizing radiation, like α particles, β particles and neutrons. This would further 
clarify melanin’s response to particulate radiation, possibly expanding radioprotective 
potential to other applications, other scenarios and several different radiation emitters, 
including radioprotection applications in nuclear medicine therapy. 
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Appendix 1 
Data analysis 
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Propagation of Uncertainty  
Being f a function of N varying parameters, 𝑓(𝑎1 , 𝑎2 , … , 𝑎𝑁). As known, 
𝑑𝑓 =  
𝜕𝑓
𝜕𝑎𝑘
𝑑𝑥𝑘
𝑁
𝑘=1
 
i.e. if 𝑎𝑘 → 𝑎𝑘 + 𝛿𝑎𝑘  , 𝑓 → 𝑓 + 𝛿𝑓 . Moreover, 
𝛿2𝑓 =  
𝜕𝑓
𝜕𝑎𝑘
𝜕𝑓
𝜕𝑎𝑗
𝛿𝑎𝑘𝛿𝑎𝑗
𝑁
𝑘
 
If  𝑎𝑘  values were the result of direct or indirect measurements, those values will be 
affected by statistical floating, translated in measurement uncertainty; which will be 
called 𝜎𝑎𝑘 . Propagation of uncertainty (or propagation of error) is the effect 
of variables' uncertainties (or errors) on the uncertainty of a function based on them. When 
the variables are the values of experimental measurements they have uncertainties due to 
measurement limitations which propagate to the combination of variables in the function. 
 
The uncertainty (or error) should be:  
𝜎𝑓
2 =   
𝜕𝑓
𝜕𝑎𝑘
 
2
𝜎𝑎𝑘
2
𝑁
𝐾=1
 
Where 𝜎𝑎𝑘
2  is the uncertainty of 𝑎𝑘 . 
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Linear Least Square Fitting Method 
The problem to know the best values of function parameters to describe a whole of 
measurements is normally called fit. The most common method consists in considering that 
best parameter estimative is that that minimize discrepancy between predicted values by 
function, 𝑓 𝑥𝑘 , and measured values 𝑓𝑘 . 
Linear least square in statistic corresponds to the maximum likelihood estimate for 
a linear regression with normally distributed error. The goals of linear least squares are to 
extract predictions from the measurements and to reduce the effect of measurement errors. 
If function represents a straight line, 𝑦 = 𝑎 + 𝑏𝑥, fitting has a simple, analytical 
solution. When each measurement has different uncertainty from the other measurements 
the parameters a and b and respective uncertainties, 𝜎𝑎  and 𝜎𝑏 , are given by: 
𝛾 =  
𝑥𝑖
2
𝜎𝑖
2  
1
𝜎𝑖
2 −    
𝑥𝑖
𝜎𝑖
2
1
 
2
𝑖𝑖
 
𝑎 =  
1
𝛾
 
𝑥𝑖
2
𝜎𝑖
2
𝑖
 
𝑦𝑖
𝜎𝑖
2
𝑖
−  
𝑥𝑖
𝜎𝑖
2  
𝑥𝑖𝑦𝑖
𝜎𝑖
2
𝑖𝑖
  
𝑏 =
1
𝛾
 
𝑥𝑖
2𝑦𝑖
2
𝜎𝑖
2
𝑖
 
1
𝜎𝑖
2
𝑖
−  
𝑥𝑖
𝜎𝑖
2  
𝑦𝑖
𝜎𝑖
2
𝑖𝑖
   
𝜎𝑎
2 =  
1
𝛾
 
𝑥𝑖
2
𝜎𝑖
2
𝑖
 
𝜎𝑏
2 =  
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𝛾
 
1
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Appendix 2 
 
Experimental Protocols  
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1. Micronuclei in cytokinesis blocked B16-F1 cells 
Adapted from Goulart de Medeiros, 2003. 
Cell cultures 
1. Seed 1×105 cells in 5 cm diameter sterile Petri dishes and complete to 5 ml 
DMEM supplemented with 10% FBS (Sigma, St Louis, MO, USA), 1% penicillin + 
streptomycin. 
 
2. Incubate at 37ºC, 5% CO2. 
 
3. At 24h of incubation perform irradiation procedure. 
 
4. At 44h of incubation, add 100 μl of cytochalasin-B (Sigma, St. Louis, MO, USA) 
to a final concentration of 12.5 μM. (6 μg/ml, stock solution 8.34 mM prepared 
in DMSO). 
Preparation of slides 
1. After a total of 72 hours of culture, harvest cells by trypsination and 
centrifugation 1500 rpm, 10 minutes, at room temperature. 
 
2. Wash twice with RPMI 1640 (pH 7.2), supplemented with 2% FBS. 
 
3. Centrifuge for 7 minutes at 800 rpm, room temperature. 
 
4. Remove supernatant, loosen pellet and subject cells to a mild hypotonic 
treatment, consisting of KCl 0.075M solution, for 2 min. 
 
5. Centrifuge for 5 minutes at 800 rpm. 
 
6. Remove supernatant and loosen pellet. 
 
7. Place small drops of cell pellet in clean dry slides, and perform smears. 
 
8. Air dry slides overnight. 
 
9. Fix with freshly prepared ice-cold methanol/acetic acid (3:1) for 20 min. 
 
10. Allow to dry and stain with 4% Giemsa in 0.01 M phosphate buffer pH 6.8 for 8 
min. 
 
11. Close the slides with Entellan® (Merck, Darmstadt, Germany). 
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2. MTT assay 
Adapted from (Mosmann 1983) 
 
1. Seed 100 μl (5 x 104) cells on each well of a 96-well plate. To avoid evaporation, do not 
use outer lines and columns of 96-well plate. 
 
2. Incubate at 37ºC, 5% CO2. 
 
3. At 24h of incubation perform irradiation procedure. 
 
4. At 48h of incubation add to each well 10 μl of MTT (0.5 mg/ml final concentration)  
 
5. At 51h add 100 μl of DMSO to each well. 
 
6. At 72h perform reading with Rosys Anthos 2010 multiwell reader spectrophotometer 
at 540nm (test wavelength) and 620nm (reference wavelength). 
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3. Determination of lipoperoxidation products by 
the MDA-TBA assay 
(Adapted from Dousset et al., 1983 and Goulart de Medeiros, 2003) 
Standards 
Tetramethoxipropane (Fluka AG, Buchs, Germany): dilute in dH2O to final 
concentrations of 0.25 to 2.5 μM. 
Blank: reaction mixture using dH2O as “sample”. 
Thiobarbituric acid reagent 
1. Add 400 mg thiobarbituric acid (TBA) (AppliChem BioChemica, Darmstadt, 
Germany) to 18 ml of 2N NaOH. 
 
2. Adjust pH 7.4 with 7% perchloric acid. 
 
3. Complete volume of 50 ml with dH2O (solution A). 
 
4. Add 2 volumes of Solution A to 1 volume of 7% perchloric acid (TBA reagent). 
Reaction with thiobarbituric acid 
1. Pipette triplicate aliquots of 1 ml post-irradiation (2-3 hours after irradiation) 
medium into screw-cap, heat resistant glass tubes, containing 25μl of BHT 0.2% in 
absolute alcohol. 
 
2. Add 1.5 μl of freshly prepared TBA reagent. 
 
3. Close the tubes tightly, vortex, and place in a boiling bath for ten minutes. 
 
4. Cool down to room temperature. 
 
5. Add 3 ml 1-butanol to each tube, close the tube tightly and vortex thoroughly. 
 
6. Centrifuge for 15 minutes at 4000 rpm. 
Quantification 
Carefully remove each organic phase into measurement cuvette, mix and measure 
fluorescence of the solution at 515 nm excitation, 553 nm emission (Shimadzo RF-5000 
Spectrofluorophotometer). 
 
 
